Natco Asks Fed Circ. To Reverse Gilead's Tamiflu Win
Generic-drug manufacturer Natco Pharma Ltd. on Monday urged the Federal Circuit to invalidate a Gilead Sciences Inc. patent for the flu drug Tamiflu, saying that a New Jersey district court's refusal...To view the full article, register now.
Already a subscriber? Click here to view full article